Regimen | Dose | Plasma Data | Lymph Data | AUCL/AUCP4-a | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AUCP4-a | CL/F4-a4-b | Vss/F4-a4-c | MRT4-d | t1/24-d | AUCL4-a | t1/24-d | |||||
MIU/kg | ng · h/ml | I.U. · h/ml4-e | ml/h/kg | ml/kg | h | ng · h/ml | I.U. · h/ml4-e | h | |||
i.v. 15-min infusion | 0.01 | 249 ± 24 (10) | 996 | 10.1 ± 1.0 (10) | 82.4 ± 8.4 (10) | 8.25 | 6.29 | 82.4 ± 10.7 (13) | 330 | 7.19 | 0.33 ± 0.07 (22) |
s.c. bolus | 0.01 | 403 ± 148 (37) | 1612 | 7.07 ± 3.29 (46) | 240 ± 66 (27) | 32.4 | 21.8 | 467 ± 424 (91) | 1868 | 12.5 | 1.20 ± 0.99 (83) |
s.c. bolus | 0.03 | 932 ± 431 (46) | 3728 | 9.09 ± 3.39 (37) | 301 ± 77 (26) | 23.7 | 14.4 | 962 ± 69 (7) | 3848 | 10.2 | 1.18 ± 0.49 (41) |
s.c. bolus | 0.1 | 1494 ± 671 (45) | 5976 | 19.7 ± 9.1 (46)4-150 | 415 ± 212 (51)4-150 | 22.8 | 13.1 | 1856 ± 504 (27) | 7424 | 10.7 | 1.36 ± 0.42 (31) |
↵4-a Data are mean ± S.D.; numbers in parentheses represent coefficient of variation as a percentage.
↵4-b CL/F significantly different when stratified by route and dose level (P = .04).
↵4-c Vss/F was significantly different when stratified by route and dose level (P = .04).
↵4-d Harmonic mean is reported for MRT and half-life.
↵4-e A specific activity of 4 MIU/mg was used to convert the PEG-IL-2 data from mass units (mg) to activity units (I.U.).
↵4-150 Comparisons of all pairs using Tukey-Kramer HSD showed that mean values for s.c. bolus, dose level 0.1 MIU/kg, was significantly different from the 0.01 MIU/kg for CL/F. For Vss/F, the mean for s.c. bolus, dose level 0.1 MIU/kg, was significantly different from the i.v. 15-min infusion dose group.